Signaling through estrogen receptors modulates telomerase activity in human prostate cancer

Journal of Clinical Investigation

Volumn 110, Issue 2, 2002, Pages 219-227

  Nanni, Simona ^a,b   Narducci, Michela ^a   Pietra, Linda Della ^a,c   Moretti, Fabiola ^a,d   Grasselli, Annalisa ^a,d   De Carli, Piero ^a   Sacchi, Ada ^a   Pontecorvi, Alfredo ^a,b   Farsetti, Antonella ^a,d  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; AROMATASE INHIBITOR; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LETROZOLE; TELOMERASE;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; RECEPTOR INTRINSIC ACTIVITY; TRANSCRIPTION REGULATION;

EID: 0036077411     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0215552     Document Type: Article

References (47)

1. A critical role for telomeres in suppressing and facilitating carcinogenesis
2. The hallmarks of cancer
3. Extension of life-span by introduction of telomerase into normal human cells
4. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span
5. Inhibition of telomerase limits the growth of human cancer cells
6. A survey of telomerase activity in human cancer
7. Molecular genetics of prostate cancer
8. Telomerase activity: A prevalent marker of malignant human prostate tissue
9. Telomerase accivity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium
10. Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells
11. Estrogen receptor-β: Implications for the prostate gland
12. Expression of estrogen receptor (ER)-α and ER-β in normal and malignant prostatic epithelial cells: Regulation by methylation and involvement in growth regulation
13. Frequent methylation of estrogen receptor in prostate cancer: Correlation with tumor progression
14. Frequent loss of estrogen receptor-β expression in prostate cancer
15. A role for estrogen receptor β in the regulation of growth of the ventral prostate
16. On the prevention and therapy of the prostate cancer by androgen administration
17. The effects of diethylstilboestrol and castration on the nucleic acid and protein metabolism of rat prostate gland
18. Estrogen receptor expression in prostate cancer and premalignant prostatic lesions
19. Receptor null mice reveal contrasting roles for estrogen receptor α and β in reproductive tissues
20. Role of estrogen receptor beta in estrogen action
21. Comparative studies of the estrogen receptors β and α and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma
22. Evaluation of androgen, estrogen (ERα and ERβ), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assay
23. Loss of estrogen receptor β expression in malignant human prostate cells in primary cultures and in prostate cancer tissues
24. Multiple estrogen function in human prostate cancer cells
25. Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium
26. Estrogen control of progesterone receptor in human breast cancer
27. Telomerase activity in human development is regulated by human telomerase reverse transcription and by alternative splicing of hTERT transcript
28. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP)
29. C-Myc target gene specificity determined by a post-DNA-binding mechanism
30. The cyclin B1 gene is actively transcribed during mitosis in HeLa cells
31. Estrogen activates telomerase
32. Cloning and characterization of human and mouse telomerase RNA gene promotor sequences
33. Identification and characterization of estrogen receptor variants in prostate cancer cell lines
34. The estrogen receptor β-isoform (Erβ) of the human estrogen receptor modulates Erα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens
35. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription
36. Transcription activation by the human estrogen receptor subtype β (ERβ) studied with ERβ and ERα receptor chimeras
37. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
38. Intracellular aromatase and its relevance to the pharmacological efficacy of aromatase inhibitors
39. Prostate cancer. An overview of an increasing dilemma
40. Endocrine therapy in the treatment of metastatic breast cancer
41. Epithelial-stromal interactions and tumor progression: Meeting summary and future directions
42. Balancing instability: Dual roles for telomerase and telomere dysfunction in tumorigenesis
43. Δ2/3 cancer-prone mouse
44. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis
45. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis
46. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans
47. Nuclear receptor coregulators: Cellular and molecular biology